Open‐Label Support for Duloxetine for the Treatment of Panic Disorder

Panic disorder with or without agoraphobia is a common, often chronic and refractory anxiety disorder. Although a number of pharmacotherapies are now indicated for panic disorder, many patients do not respond to available interventions. We hypothesized that duloxetine, a serotonin‐norepinephrine reu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:CNS Neurosci Ther
Main Authors: Simon, Naomi M., Kaufman, Rebecca E., Hoge, Elizabeth A., Worthington, John J., Herlands, Nannette N., Owens, Maryann E., Pollack, Mark H.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2009
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494018/
https://ncbi.nlm.nih.gov/pubmed/19228176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2008.00076.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki